Clinician to CEO : Export Your Medical Device With Confidence By Overcoming Go To Market Roadblocks For Medtech Growth

When your MedTech launch has several weak points, how do you know which one to fix first before you waste 90 days improving the wrong thing?MedTech founders rarely fail because the device is poor. More often, they stall because they improve the wrong part of their launch first. When product, proof, pathway, and people all have room for improvement, deciding where to focus becomes critical. In this episode, Hakeem breaks down a practical decision rule that helps you identify the one move most likely to unlock real contracts and meaningful revenue.By listening, you’ll:Learn why the lowest-scoring weakness is not always the first problem you should solveUnderstand how commercial conversations reveal whether proof, pathway, or people is the real revenue constraintUse a simple 90-day decision filter to prioritize the move most likely to accelerate traction this quarterPress play now to identify the one change that can move your MedTech launch closer to real contracts and meaningful revenueBook a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.

Many clinicians build Medical Devices that solve real clinical problems.They secure regulatory approval.They get positive feedback from early users.They even generate interest from hospitals or distributors.And yet… adoption stalls.Not because the product is poor — but because something critical in the launch is structurally weak.In this episode, we break down the four Ps that determine whether a MedTech product gets adopted or simply admired.This is not textbook marketing theory.It’s the real-world framework that reveals exactly where your go-to-market strategy is breaking down.You’ll discover:Why regulatory approval and engineering perfection don’t guarantee adoptionThe difference between clinical enthusiasm and commercial proofWhy hospitals buy through processes — not passionThe hidden influence of decision-making units inside healthcare systemsWhy distributors and internal teams must align around the same commercial structureIf you’re a clinician trying to turn a working prototype into a scalable Medical Device business, this framework will help you quickly identify the structural weakness slowing your launch.Because technically strong MedTech products rarely fail due to innovation.They fail when one of the four Ps breaks down.In the episode, we also walk through a quick self-audit so you can score your own launch and identify the single area that could unlock momentum in the next 90 days.Listen now and see where your go-to-market strategy might be exposed.Message me via DM on LinkedinBook a 30 min discovery call for the Healthcare Export Accelerator ProgrammeThis podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.

You’ve done the hard part.You’ve secured regulatory approval. You’ve got two pilot sites running. You’ve even got distributor interest.But sales still aren’t landing the way you expected.Now you’ve got 90 days. Limited runway. Board pressure building.And you can only prioritise one move.So what do you focus on?Do you activate the distributor and push for reach?Do you hire commercial support to build structure?Do you refine your messaging and economic case?Or do you double down somewhere else entirely?In this episode, we break down how clinician founders should prioritise when everything feels urgent — and why most MedTech businesses stall not because the product isn’t strong, but because the commercial leverage isn’t.You’ll discover:Why regulatory approval is permission — not tractionThe difference between interest and evidence (and why only one protects your runway)The hidden risk of activating distributors too earlyWhy activity and progress are not the same thingThe decision framework that turns early traction into scalable momentumIf you’re a clinician building a Medical Device and trying to simplify your go-to-market strategy, this episode will challenge how you think about traction, revenue and exporting.Because the difference between a working prototype and an international MedTech business isn’t technical strength.It’s commercial proof.Hit play and decide what you would prioritise — before you hear what we would do.Message me via DM on LinkedinBook a 30 min discovery call for the Healthcare Export Accelerator ProgrammeThis podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.

Clinicians saying they love your product doesn’t mean hospitals will adopt it — and that gap is where clinician-led MedTech companies burn cash and lose momentum.In this episode, Hakeem is joined by Mark Tudor (20+ years in commercial leadership and advisory roles in medical devices) to break down why technically strong products stall after launch, how hospitals really decide what to buy, and how to build the commercial foundations that drive adoption, sales, and export readiness.Learn why commercial planning must run in parallel with product and regulatory workUnderstand what hospitals actually buy (risk management, simplicity, and economic clarity — not “better performance”)Get a practical lens for stakeholder mapping, validation beyond friendly opinions, and avoiding “inventor syndrome”Helping clinicians simplify their go-to-market strategy so they can stop guessing and turn their working prototypes into international MedTech businesses.Decision point scenario: You’re advising a clinician founder with regulatory approval, two pilot sites, one keen-but-unproven distributor, limited runway, and 90 days before board pressure. You can only prioritise one focus — what do you choose and why? (Mark answers in the next episode.)If you tell me whether you want this episode to lean harder into adoption, hospital buying decisions, or export/distributor readiness, I’ll pick the best 3 titles from above and tighten them even more.Message me via DM on LinkedinBook a 30 min discovery call for the Healthcare Export Accelerator ProgrammeThis podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.

If you only had 14 months of runway left, no international sales team, and one shot at entering a new export market… would you choose the one that looks impressive or the one that actually gives you the highest probability of revenue?Most MedTech founders believe they’re making rational expansion decisions but under pressure, choices get driven by ego, investor optics, or the allure of a “big” market. With limited runway, one wrong move can quietly burn capital and delay global traction.In the previous episode, you built your export business plan. Today, we pressure-test it. We walk through the exact scenario I posed and reveal which market actually wins when you apply disciplined strategy instead of ambition.In this episode, you’ll see exactly how to eliminate two markets and confidently choose the one most likely to generate traction within 12 months.By listening, you’ll:See how to apply your export business plan to eliminate the wrong markets with confidenceLearn how to balance ambition with execution probability inside a 14-month runwayUse a 180-day reality filter to validate traction before committing capital and credibilityPress play now to learn how to choose the export market that compounds your growth not the one that drains your runway.Message me via DM on LinkedinBook a 30 min discovery call for the Healthcare Export Accelerator ProgrammeThis podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.